Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

48461 - 48470 of 60077 results found

Evaluation of risk management in a natalizumab home infusion procedure

Date
Thursday, May 18, 2023 - 4:00 AM
Description
Natalizumab is a well-established disease-modifying therapy used in active multiple sclerosis (MS). The most serious adverse event is progressive multifocal leukoencephalopathy. For safety reasons, hospital implementation is mandatory. The SARS-CoV-2

SARS-CoV2 in public spaces in West London, UK during COVID-19 pandemic

Date
Thursday, May 18, 2023 - 4:00 AM
Description
CONCLUSION: During a period of partial opening during the COVID-19 pandemic in London, we detected SARS-CoV2 RNA in the air of hospital waiting areas and wards and of London Underground train carriage. More research is needed to determine the

Altered tissue oxygenation in patients with post COVID-19 syndrome

Date
Thursday, May 18, 2023 - 4:00 AM
Description
CONCLUSIONS: This study provides evidence that the rate of tissue oxygen consumption is persistently altered in PCS and that PCS patients show an even slower decline in tissue oxygenation during occlusion than CVD patients. Our observations may at